Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125276582 | 12527658 | 2 | F | 20160907 | 20160705 | 20160909 | EXP | US-PFIZER INC-2016320484 | PFIZER | 74.00 | YR | F | Y | 0.00000 | 20160909 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125276582 | 12527658 | 1 | PS | ZYVOX | LINEZOLID | 1 | 600 MG, 2X/DAY | Y | 21130 | 600 | MG | FILM-COATED TABLET | BID | ||||||
| 125276582 | 12527658 | 2 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, AT NIGHT | 0 | 50 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125276582 | 12527658 | 1 | Infection |
| 125276582 | 12527658 | 2 | Sleep disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125276582 | 12527658 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125276582 | 12527658 | Alopecia | |
| 125276582 | 12527658 | Eating disorder | |
| 125276582 | 12527658 | Product use issue | |
| 125276582 | 12527658 | Volume blood decreased | |
| 125276582 | 12527658 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125276582 | 12527658 | 1 | 20150605 | 0 |